The share touched its 52-week high Rs 677.45 and 52-week low Rs 445.85 on 27 September, 2018 and 20 September, 2019, respectively.
Moneycontrol News
@moneycontrolcom
Shares of pharma major Cipla fell more than 1 percent intraday on September 23 after the company received Establishment Inspection Report (EIR) from the USFDA.
The United States Food and Drug Administration (USFDA) has carried out inspection at the company's API manufacturing facility in Virgonagar, Bengaluru, from July 15-19, 2019.
The company has received the EIR, indicating closure of the inspection.
At 0940 hrs, Cipla was quoting at Rs 458.75, down Rs 4.65, or 1 percent on the BSE.
The share touched its 52-week high of Rs 677.45 and its 52-week low of Rs 445.85 on September 27, 2018 and September 20, 2019, respectively.
Currently, it is trading 32.28 percent below its 52-week high and 2.89 percent above its 52-week low.Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.First Published on Sep 23, 2019 09:53 am
